Markup | Genome Research

Table 1.

Patient sample information

Sample	RNA-seq ID	Sex	Clinical diagnosis	Age at death	Disease duration	% Insoluble hnRNPH	Group
C91	CGND HRA 00714	F	ALS	64	1–1.5 yr	87.2	C9high
C92	CGND HRA 00728	F	ALS	64	0.5 yr	56	C9low
C93	CGND HRA 00715	F	ALS	58	1–1.5 yr	94.7	C9high
C94	CGND HRA 00730	M	ALS-FTD	60	0.5–1 yr	41.3	C9low
C95	CGND HRA 00729	F	ALS	65	7–7.5 yr	89.2	C9high
C96	CGND HRA 00716	M	ALS	73	4.5 yr	37.2	C9low
C98	CGND HRA 00726	M	ALS	59	1 yr	81.8	C9high
C99	CGND HRA 00718	M	ALS	70	<2 yr	15.8	C9low
C910	CGND HRA 00453	F	FTD	75	9 yr	95.3	C9high
C911	CGND HRA 00719	M	ALS-FTD	73	2 yr	89.5	C9high
C912	CGND HRA 00720	F	ALS	57	1 yr	33.2	C9low
C913	CGND HRA 00713	F	ALS-FTD	68	6 yr	27	C9low
C916	CGND HRA 00707	F	ALS-FTD	68	6 yr	40.3	C9low
non6	CGND HRA 00206	F	Non-neurological control	54	n/a	n/a	Control
non9	CGND HRA 00721	F	Non-neurological control	90+	n/a	n/a	Control
non10	CGND HRA 00077	F	Non-neurological control	90+	n/a	n/a	Control
non11	CGND HRA 00197	F	Non-neurological control	70	n/a	n/a	Control
non12	CGND HRA 00196	F	Non-neurological control	52	n/a	n/a	Control
non13	CGND HRA 00753	M	Non-neurological control	89	n/a	n/a	Control